Survival score to characterize prognosis in inoperable stage III NSCLC after chemoradiotherapy

BACKGROUND: Stage III non-small cell lung cancer (NSCLC) represents a heterogeneous disease regarding principal patient- and tumor characteristics. A simple score may aid in personalizing multimodal therapy. METHODS: The data of 99 consecutive patients with performance status ECOG 0–1 treated until...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Transl Lung Cancer Res
Glavni autori: Taugner, Julian, Käsmann, Lukas, Eze, Chukwuka, Dantes, Maurice, Roengvoraphoj, Olarn, Gennen, Kathrin, Karin, Monika, Petruknov, Oleg, Tufman, Amanda, Belka, Claus, Manapov, Farkhad
Format: Artigo
Jezik:Inglês
Izdano: AME Publishing Company 2019
Teme:
Original Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6835102/
https://ncbi.nlm.nih.gov/pubmed/31737496
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/tlcr.2019.09.19
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items